Methods to screen for antibiotic agents and their use in treatment of opportunistic infections
AssigneeBrown University Research Foundation
InventorsSusan Gerbi, Thilo Sascha Lange, Anton Borovjagin
Life of this patent
Estimating the term…
Loading patent…
AssigneeBrown University Research Foundation
InventorsSusan Gerbi, Thilo Sascha Lange, Anton Borovjagin
Estimating the term…
The present invention provides novel targets in eukaryotic cells for antibiotic agents and methods for identification of antibiotic agents affecting such targets and the use of the identified antibiotic agents in treatment of opportunistic infections in eukaryotic hosts. The invention is based upon the identification of species specific 5′ hinge and 3′ hinge regions of U3 small nucleolar ribonucleic acid (snoRNA). The present invention discloses that the external transcribed spacer (ETS) of the ribosomal RNA precursor (pre-rRNA) comprises sequences that are complementary to the 5′ and 3′ hinge regions of U3 snoRNA. The invention further discloses that sequence substitutions of the 5′ hinge or 3′ hinge region of U3 snoRNA severely compromise or fully inhibit the cleavage events at sites 1 and 2 in rRNA processing necessary to form mature 18S rRNA which is a vital component of the small subunit of ribosomes of all eukaryotes.
A method of screening for an antibiotic agent comprising the steps of
A method of screening for an antibiotic agent comprising the steps of
A method of screening for an antibiotic agent comprising the steps of
A method of screening for an antibiotic agent comprising the steps of
A method of screening for an antibiotic agent comprising the steps of
A method of screening for an antibiotic agent comprising the steps of
A method of screening for an antibiotic agent comprising the steps of
A method of inhibiting cell growth comprising contacting the cell with an antibiotic agent under conditions which permit inhibition of pre-rRNA processing wherein said inhibition of processing inhibits cell growth.
A method of inhibiting cell growth comprising contacting the cell with an antibiotic agent that inhibits synthesis of the ribosome under conditions which permit inhibition of synthesis of the ribosome wherein said inhibition of synthesis of the ribosome inhibits cell growth.
A method of treating an opportunistic infection comprising administering an antibiotic agent to a eukaryotic host suspect of or infected by a pathogen in an amount sufficient to reduce or prevent said opportunistic infection wherein said antibiotic agent inhibits processing of pre-rRNA of said pathogen.
A method of treating an opportunistic infection comprising administering an antibiotic agent to a eukaryotic host suspect of or infected by a eukaryotic pathogen in an amount sufficient to reduce or prevent said opportunistic infection, and wherein said antibiotic agent inhibits protein synthesis of said pathogen.
A method of treating an opportunistic infection comprising administering an antibiotic agent to a eukaryotic host suspect of or infected by a eukaryotic pathogen in an amount sufficient to reduce or prevent said opportunistic infection wherein said antibiotic agent inhibits cell growth of said pathogen.
A method of treating an opportunistic infection comprising administering an antibiotic agent to a eukaryotic host suspect of or infected by a eukaryotic pathogen in an amount agent sufficient to reduce or prevent said opportunistic infection wherein said antibiotic inhibits cell division of said pathogen thereby inhibiting the increase of the cell number of said pathogen.
A method of treating an opportunistic infection comprising administering an antibiotic agent to a eukaryotic host suspect of or infected by a eukaryotic pathogen in an amount sufficient to reduce or prevent said opportunistic infection, wherein said antibiotic agent inhibits synthesis of the ribosome, and wherein said antibiotic agent inhibits protein synthesis by said pathogen.
A method of treating an opportunistic infection comprising administering an antibiotic agent to a eukaryotic host suspect of or infected by a eukaryotic pathogen in an amount sufficient to reduce or prevent said opportunistic infection, wherein said antibiotic agent promotes cell death of said pathogen.
A method of inhibiting cell growth comprising contacting the cell with an antibiotic agent that wherein said antibiotic agent has the capacity to inhibit binding between a recombinant RNA comprising 5′ and 3′ hinge regions of U3 snoRNA and an RNA comprising pre-rRNA under conditions which permit inhibition of protein synthesis wherein said inhibition of protein synthesis inhibits cell growth.
Dependencies are inferred from the claim text.